17β-Benzoyloxy-androsta-1,4-dien-3-one
CAS : 19041-66-8
Ref. 3D-UAA04166
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Informations sur le produit
- (17β)-17-(Benzoyloxy)androsta-1,4-dien-3-one
- 17beta-Hydroxyandrosta-1,4-dien-3-one benzoate
- 3-Oxoandrosta-1,4-Dien-17-Yl Benzoate
- Androsta-1,4-dien-3-one, 17-(benzoyloxy)-, (17β)-
- Androsta-1,4-dien-3-one, 17β-hydroxy-, benzoate
- Androstadienolone benzoate
- Boldenone benzoate
17β-Benzoyloxy-androsta-1,4-dien-3-one is an analog of androstenedione that has been shown to have anticancer properties. This compound inhibits protein kinases involved in cell cycle regulation, such as cyclin-dependent kinase (CDK) 2 and CDK4, leading to apoptosis in cancer cells. It has been tested on human cancer cell lines and shown to be effective against several types of tumors, including breast, prostate, and lung cancers. Additionally, this compound has been found in the urine of Chinese individuals and may have potential as a diagnostic marker for certain types of cancer. As an inhibitor of CDKs, 17β-Benzoyloxy-androsta-1,4-dien-3-one represents a promising new class of anticancer drugs with potential therapeutic applications.
Propriétés chimiques
Question d’ordre technique sur : 3D-UAA04166 17β-Benzoyloxy-androsta-1,4-dien-3-one
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
